| 000 | 01349nam a22001817a 4500 | ||
|---|---|---|---|
| 008 | 241223b2022 |||||||| |||| 00| 0 eng d | ||
| 020 | _a9780128240670 | ||
| 245 |
_aManaging treatment-resistant depression _bRoad to novel therapeutics _h[E-book] |
||
| 260 |
_aLondon _bAcademic Press _c2022 |
||
| 520 | _aManaging Treatment-Resistant Depression: Road to Novel Therapeutics defines TRD for readers, discussing the clinical and epidemiological predictors, economic burden and neurobiological factors. In addition, staging methods for treatment resistance are fully covered in this book, including serotonin specific reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, other classes of antidepressants, including tricyclic antidepressants and monoamine oxidase inhibitors, augmentation strategies, and newer antidepressant treatments like ketamine and esketamine. In addition, evidence supporting the use of psychotherapies and neuromodulation strategies are also reviewed. Written by top experts in the field, this book is the first of its kind to review all methods of treatment for TRD. | ||
| 650 | 4 |
_aDepression _95848 |
|
| 650 | 4 |
_aPsychotherapy _97609 |
|
| 650 | 4 |
_aAntidepressive agents _95239 |
|
| 700 | 1 |
_aQuevedo, Joao _eEditor |
|
| 700 | 1 |
_aBobo, William V. _eEditor |
|
| 700 | 1 |
_aRiva-Posse, Patricio _eEditor |
|
| 942 | _n0 | ||
| 999 |
_c105796 _d105796 |
||